🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to investigate the efficacy of nemol...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01
Trial ID
NCT05056779
Treatments Being Tested
The main purpose of the study was to assess the efficacy and safety of nemo...
Status
Completed
Location
Galderma Investigational Site 8749
Start Date
2019-06-30
Trial ID
NCT03989349
Treatments Being Tested
The main purpose of the study was to assess the efficacy and safety of nemo...
Status
Completed
Location
Galderma Investigational Site 8880
Start Date
2019-06-27
Trial ID
NCT03985943
Treatments Being Tested
The aim of this study is to assess the safety and efficacy of nemolizumab i...
Status
Completed
Location
LKH-Univ. Klinikum Graz
Start Date
2017-10-02
Trial ID
NCT03181503
Treatments Being Tested
The primary objective of this study is to assess the PK/PD relationship of ...
Status
Active Not Recruiting
Location
Galderma Investigational Site (site# 8893)
Start Date
2025-10-20
Trial ID
NCT07074977
Treatments Being Tested
The primary objective was to assess the efficacy of nemolizumab (CD14152) c...
Status
Completed
Location
Galderma Investigational Site
Start Date
2020-09-11
Trial ID
NCT04501666
Treatments Being Tested
The main objective of this study is to assess the long-term durability of r...
Status
Completed
Location
Galderma Investigational Site 8521
Start Date
2022-01-24
Trial ID
NCT05052983
Treatments Being Tested
The primary objective was to assess the efficacy of nemolizumab (CD14152) c...
Status
Completed
Location
Galderma Investigational Site
Start Date
2020-08-11
Trial ID
NCT04501679
Treatments Being Tested
This is a bridging study only for Chinese subjects. The goal of this clinic...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-28
Trial ID
NCT07762833
Treatments Being Tested
The purpose of this study was to evaluate the efficacy of nemolizumab compa...
Status
Completed
Location
Galderma Investigational Site 9989
Start Date
2022-03-18
Trial ID
NCT05075408
Treatments Being Tested